- Home
- LAES vs SGMO Comparison
LAES vs SGMO Comparison
Compare LAES & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAES
- SGMO
- Stock Information
- Founded
- LAES 2022
- SGMO 1995
- Country
- LAES Switzerland
- SGMO United States
- Employees
- LAES N/A
- SGMO N/A
- Industry
- LAES Semiconductors
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LAES Technology
- SGMO Health Care
- Exchange
- LAES Nasdaq
- SGMO Nasdaq
- Market Cap
- LAES 483.1M
- SGMO 488.2M
- IPO Year
- LAES N/A
- SGMO 2000
- Fundamental
- Price
- LAES $4.24
- SGMO $1.09
- Analyst Decision
- LAES Strong Buy
- SGMO Buy
- Analyst Count
- LAES 1
- SGMO 5
- Target Price
- LAES $1.75
- SGMO $5.20
- AVG Volume (30 Days)
- LAES 80.8M
- SGMO 10.5M
- Earning Date
- LAES 09-25-2024
- SGMO 03-12-2025
- Dividend Yield
- LAES N/A
- SGMO N/A
- EPS Growth
- LAES N/A
- SGMO N/A
- EPS
- LAES N/A
- SGMO N/A
- Revenue
- LAES $20,135,000.00
- SGMO $52,291,000.00
- Revenue This Year
- LAES N/A
- SGMO N/A
- Revenue Next Year
- LAES N/A
- SGMO $5.97
- P/E Ratio
- LAES N/A
- SGMO N/A
- Revenue Growth
- LAES N/A
- SGMO N/A
- 52 Week Low
- LAES $0.29
- SGMO $0.30
- 52 Week High
- LAES $11.00
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- LAES 48.81
- SGMO 35.59
- Support Level
- LAES $4.04
- SGMO $1.00
- Resistance Level
- LAES $5.25
- SGMO $1.18
- Average True Range (ATR)
- LAES 1.71
- SGMO 0.16
- MACD
- LAES -0.52
- SGMO -0.06
- Stochastic Oscillator
- LAES 15.92
- SGMO 9.89
About LAES SEALSQ Corp
SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. Its vaultIC range offers a complete set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.